Vietnam’s second homegrown candidate COVID-19 vaccine Covivac which is under clinical trials (Source: VNA) Hanoi (VNA) – Vietnam is set to master the production technology of 10 vaccines used for humans and be capable of producing at least three by 2025, according to a national sci-tech programme on human vaccine production research by 2030 freshly approved by Deputy Prime Minister Vu Duc Dam.
With the targets to rise to 15 and at least five, respectively, in 2030, the programme’s objectives are to study and master the technology of vaccine production for human use; and to boost the capacity of domestic vaccine research and production organisations and enterprises, making them ready to deal with newly arising epidemics.
To realise such goals, the programme sets the tasks of completing the legal framework and mechanisms in the field, encouraging research and international cooperation, the application of advanced technologies, and the establishment of capable research teams, among other works.
Human resources development and investment in upgrading related research equipment are also listed among support activities under the programme.
Per the programme, organisations and firms participating in vaccine research and technology transfer will be subject to preferential policies like those applied on prioritised high-tech products.
Meanwhile, regarding vaccines for epidemics prevention and control, their costs of research, testing, pilot production, assessment, buying insurance, and assisting volunteers are 100 percent subsidized./.
VNA
